Aspen M&A loan to sign before November
The general syndicate stage for South African pharma, Aspen's $2bn M&A facility is due to sign by the end of this month.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
